Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | 63,860 | reported | 18 May 2026 | tx 194+1,366,208−1,539,247 |
| Nivalis Therapeutics, Inc. | 11,368 | reported | 04 Jan 2017 | tx 10+154,166−72,624 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 15.44 USD | 10b5-1 |
| 18 May 2026 | SALE | Mineralys Therapeutics, Inc. | 417 | 27.55 USD | 10b5-1 |
| 18 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 0.00 USD | 10b5-1deriv |
| 13 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 4,166 | 14.25 USD | 10b5-1 |
| 11 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 2,171 | 16.00 USD | 10b5-1 |
| 11 May 2026 | SALE | Mineralys Therapeutics, Inc. | 2,171 | 29.71 USD | 10b5-1 |
| 12 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6,348 | 1.08 USD | 10b5-1 |
| 12 May 2026 | SALE | Mineralys Therapeutics, Inc. | 6,348 | 29.36 USD | 10b5-1 |
| 13 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 3,541 | 10.20 USD | 10b5-1 |
| 13 May 2026 | SALE | Mineralys Therapeutics, Inc. | 14,056 | 28.58 USD | 10b5-1 |
| 11 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 2,171 | 0.00 USD | 10b5-1deriv |
| 12 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6,348 | 0.00 USD | 10b5-1deriv |
| 13 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 3,541 | 0.00 USD | 10b5-1deriv |
| 13 May 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 4,166 | 0.00 USD | 10b5-1deriv |
| 17 Mar 2026 | SALE | Mineralys Therapeutics, Inc. | 417 | 25.65 USD | |
| 17 Mar 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 15.44 USD | |
| 17 Mar 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 417 | 0.00 USD | deriv |
| 13 Mar 2026 | SALE | Mineralys Therapeutics, Inc. | 253 | 27.82 USD | |
| 13 Mar 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 4,167 | 14.25 USD | |
| 13 Mar 2026 | SALE | Mineralys Therapeutics, Inc. | 10,726 | 25.91 USD | |
| 13 Mar 2026 | SALE | Mineralys Therapeutics, Inc. | 3,079 | 27.37 USD | |
| 12 Mar 2026 | SALE | Mineralys Therapeutics, Inc. | 6,348 | 27.37 USD | |
| 12 Mar 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6,348 | 1.08 USD | |
| 13 Mar 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 3,542 | 10.20 USD | |
| 12 Mar 2026 | EXERCISE | Mineralys Therapeutics, Inc. | 6,348 | 0.00 USD | deriv |